
Akm E. Ullah
Examiner (ID: 10221, Phone: (571)272-2361 , Office: P/2874 )
| Most Active Art Unit | 2874 |
| Art Unit(s) | 2874, 2606, 2501, 1734, 2899, 3621, 2838 |
| Total Applications | 3400 |
| Issued Applications | 3065 |
| Pending Applications | 95 |
| Abandoned Applications | 245 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6607448
[patent_doc_number] => 20100099116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-22
[patent_title] => 'Methods for Analysis of Hedgehog Pathway Inhibitors'
[patent_app_type] => utility
[patent_app_number] => 12/521079
[patent_app_country] => US
[patent_app_date] => 2008-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 5534
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20100099116.pdf
[firstpage_image] =>[orig_patent_app_number] => 12521079
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/521079 | Methods for Analysis of Hedgehog Pathway Inhibitors | Jan 13, 2008 | Abandoned |
Array
(
[id] => 7818486
[patent_doc_number] => 20120065106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'Methods and Compositions for Enhanced Protein Expression and Purification'
[patent_app_type] => utility
[patent_app_number] => 12/521468
[patent_app_country] => US
[patent_app_date] => 2007-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 18011
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20120065106.pdf
[firstpage_image] =>[orig_patent_app_number] => 12521468
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/521468 | Methods and compositions for enhanced protein expression and purification | Dec 27, 2007 | Issued |
Array
(
[id] => 4514733
[patent_doc_number] => 07932087
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-04-26
[patent_title] => 'Method of expressing recombinant protein in CHO cells'
[patent_app_type] => utility
[patent_app_number] => 11/962261
[patent_app_country] => US
[patent_app_date] => 2007-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7827
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/932/07932087.pdf
[firstpage_image] =>[orig_patent_app_number] => 11962261
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/962261 | Method of expressing recombinant protein in CHO cells | Dec 20, 2007 | Issued |
Array
(
[id] => 4845920
[patent_doc_number] => 20080182328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'Mammalian extraembryonic endoderm cells and methods of isolation'
[patent_app_type] => utility
[patent_app_number] => 12/004299
[patent_app_country] => US
[patent_app_date] => 2007-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 23447
[patent_no_of_claims] => 53
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0182/20080182328.pdf
[firstpage_image] =>[orig_patent_app_number] => 12004299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/004299 | Mammalian extraembryonic endoderm cells and methods of isolation | Dec 18, 2007 | Abandoned |
Array
(
[id] => 6535851
[patent_doc_number] => 20100015620
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'CANCER-LINKED GENES AS BIOMARKERS TO MONITOR RESPONSE TO IMPDH INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 12/448031
[patent_app_country] => US
[patent_app_date] => 2007-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11689
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015620.pdf
[firstpage_image] =>[orig_patent_app_number] => 12448031
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/448031 | CANCER-LINKED GENES AS BIOMARKERS TO MONITOR RESPONSE TO IMPDH INHIBITORS | Dec 5, 2007 | Abandoned |
Array
(
[id] => 6537196
[patent_doc_number] => 20100015704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-21
[patent_title] => 'PROCESS FOR THE ENRICHMENT OF MELANOCYTES BY MEANS OF MODIFIED SURFACES'
[patent_app_type] => utility
[patent_app_number] => 12/447596
[patent_app_country] => US
[patent_app_date] => 2007-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5874
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20100015704.pdf
[firstpage_image] =>[orig_patent_app_number] => 12447596
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/447596 | PROCESS FOR THE ENRICHMENT OF MELANOCYTES BY MEANS OF MODIFIED SURFACES | Dec 5, 2007 | Abandoned |
Array
(
[id] => 4534815
[patent_doc_number] => 07872101
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2011-01-18
[patent_title] => 'Modulators of the orphan G protein-coupled receptors GPR78 and GPR26'
[patent_app_type] => utility
[patent_app_number] => 11/949306
[patent_app_country] => US
[patent_app_date] => 2007-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 30700
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/872/07872101.pdf
[firstpage_image] =>[orig_patent_app_number] => 11949306
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/949306 | Modulators of the orphan G protein-coupled receptors GPR78 and GPR26 | Dec 2, 2007 | Issued |
Array
(
[id] => 4852487
[patent_doc_number] => 20080318230
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'GENE EXPRESSION MARKERS FOR RESPONSE TO EGFR INHIBITOR DRUGS'
[patent_app_type] => utility
[patent_app_number] => 11/949535
[patent_app_country] => US
[patent_app_date] => 2007-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11944
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20080318230.pdf
[firstpage_image] =>[orig_patent_app_number] => 11949535
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/949535 | GENE EXPRESSION MARKERS FOR RESPONSE TO EGFR INHIBITOR DRUGS | Dec 2, 2007 | Abandoned |
Array
(
[id] => 4813308
[patent_doc_number] => 20080193939
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'CORNEODESMOSIN BASED TEST AND MODEL FOR INFLAMMATORY DISEASE'
[patent_app_type] => utility
[patent_app_number] => 11/947600
[patent_app_country] => US
[patent_app_date] => 2007-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 13791
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193939.pdf
[firstpage_image] =>[orig_patent_app_number] => 11947600
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/947600 | CORNEODESMOSIN BASED TEST AND MODEL FOR INFLAMMATORY DISEASE | Nov 28, 2007 | Abandoned |
Array
(
[id] => 6304332
[patent_doc_number] => 20100068715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'MARKER GENES FOR USE IN THE IDENTIFICATION OF CHONDROCYTE PHENOTYPIC STABILITY AND IN THE SCREENING OF FACTORS INFLUENCING CARTILAGE PRODUCTION'
[patent_app_type] => utility
[patent_app_number] => 12/515488
[patent_app_country] => US
[patent_app_date] => 2007-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 13538
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068715.pdf
[firstpage_image] =>[orig_patent_app_number] => 12515488
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/515488 | MARKER GENES FOR USE IN THE IDENTIFICATION OF CHONDROCYTE PHENOTYPIC STABILITY AND IN THE SCREENING OF FACTORS INFLUENCING CARTILAGE PRODUCTION | Nov 22, 2007 | Abandoned |
Array
(
[id] => 4748258
[patent_doc_number] => 20080156328
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-03
[patent_title] => 'SOLENOID AIR/OXYGEN SYSTEM FOR USE WITH AN ADAPTIVE OXYGEN CONTROLLER AND THERAPEUTIC METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 11/938289
[patent_app_country] => US
[patent_app_date] => 2007-11-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4055
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20080156328.pdf
[firstpage_image] =>[orig_patent_app_number] => 11938289
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/938289 | SOLENOID AIR/OXYGEN SYSTEM FOR USE WITH AN ADAPTIVE OXYGEN CONTROLLER AND THERAPEUTIC METHODS OF USE | Nov 10, 2007 | Abandoned |
Array
(
[id] => 6256578
[patent_doc_number] => 20100029509
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-04
[patent_title] => 'NOVEL METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/513953
[patent_app_country] => US
[patent_app_date] => 2007-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 12879
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20100029509.pdf
[firstpage_image] =>[orig_patent_app_number] => 12513953
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/513953 | NOVEL METHODS | Nov 6, 2007 | Abandoned |
Array
(
[id] => 4813311
[patent_doc_number] => 20080193942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'System and method for identifying erythropoietin-responsive genes'
[patent_app_type] => utility
[patent_app_number] => 11/982958
[patent_app_country] => US
[patent_app_date] => 2007-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 9147
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193942.pdf
[firstpage_image] =>[orig_patent_app_number] => 11982958
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/982958 | System and method for identifying erythropoietin-responsive genes | Nov 5, 2007 | Abandoned |
Array
(
[id] => 4965325
[patent_doc_number] => 20080108145
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-08
[patent_title] => 'GENES ASSOCIATED WITH OSTEOARTHRITIS'
[patent_app_type] => utility
[patent_app_number] => 11/933473
[patent_app_country] => US
[patent_app_date] => 2007-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5382
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0108/20080108145.pdf
[firstpage_image] =>[orig_patent_app_number] => 11933473
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/933473 | GENES ASSOCIATED WITH OSTEOARTHRITIS | Oct 31, 2007 | Abandoned |
Array
(
[id] => 6577031
[patent_doc_number] => 20100047261
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'BASE-MODIFIED RNA FOR INCREASING THE EXPRESSION OF A PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 12/446912
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 29340
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20100047261.pdf
[firstpage_image] =>[orig_patent_app_number] => 12446912
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/446912 | BASE-MODIFIED RNA FOR INCREASING THE EXPRESSION OF A PROTEIN | Oct 30, 2007 | Abandoned |
Array
(
[id] => 4726711
[patent_doc_number] => 20080206252
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Novel Polypeptides, and Nucleic Acids Encoding the Same'
[patent_app_type] => utility
[patent_app_number] => 11/931835
[patent_app_country] => US
[patent_app_date] => 2007-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 36067
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206252.pdf
[firstpage_image] =>[orig_patent_app_number] => 11931835
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/931835 | Novel Polypeptides, and Nucleic Acids Encoding the Same | Oct 30, 2007 | Abandoned |
Array
(
[id] => 9482783
[patent_doc_number] => 08728733
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2014-05-20
[patent_title] => 'Methyl-CpG island-associated genome signature tags'
[patent_app_type] => utility
[patent_app_number] => 11/926203
[patent_app_country] => US
[patent_app_date] => 2007-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22447
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 313
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11926203
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/926203 | Methyl-CpG island-associated genome signature tags | Oct 28, 2007 | Issued |
Array
(
[id] => 4916207
[patent_doc_number] => 20080096808
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'USE OF RAPAMYCIN TO INHIBIT RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS'
[patent_app_type] => utility
[patent_app_number] => 11/924949
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7320
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096808.pdf
[firstpage_image] =>[orig_patent_app_number] => 11924949
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/924949 | USE OF RAPAMYCIN TO INHIBIT RESPONSE AND INDUCE TOLERANCE TO GENE THERAPY VECTOR AND ENCODED TRANSGENE PRODUCTS | Oct 25, 2007 | Abandoned |
Array
(
[id] => 4898907
[patent_doc_number] => 20080118521
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'GENE EXPRESSION ASSOCIATED WITH OSTEOBLAST DIFFERENTIATION'
[patent_app_type] => utility
[patent_app_number] => 11/924367
[patent_app_country] => US
[patent_app_date] => 2007-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23606
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118521.pdf
[firstpage_image] =>[orig_patent_app_number] => 11924367
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/924367 | GENE EXPRESSION ASSOCIATED WITH OSTEOBLAST DIFFERENTIATION | Oct 24, 2007 | Abandoned |
Array
(
[id] => 5422413
[patent_doc_number] => 20090148868
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-11
[patent_title] => 'JAB1 AS A PROGNOSTIC MARKER AND A THERAPEUTIC TARGET FOR HUMAN CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/874838
[patent_app_country] => US
[patent_app_date] => 2007-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 38601
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20090148868.pdf
[firstpage_image] =>[orig_patent_app_number] => 11874838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/874838 | JAB1 as a prognostic marker and a therapeutic target for human cancer | Oct 17, 2007 | Issued |